Search research articles
Contact Us
Filters
Showing results (1-10 of 72) with videos related to
Page
of 8
Sort By:
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique
|
August 13, 2002
Beneficiary cost sharing under Canadian provincial prescription drug benefit programs: history and assessment
Paul Grootendorst
Expert Review of Pharmacoeconomics & Outcomes Research
|
August 13, 2009
How should we support pharmaceutical innovation?
Paul Grootendorst
BMC Health Services Research
|
November 4, 2022
Pharmacy location and medical need: regional evidence from Canada
Paul Grootendorst
Healthcare Policy = Politiques De Sante
|
November 17, 2015
Canada's New Generic Pricing Policy: A Reasoned Approach to a Challenging Problem
Aidan Hollis, Paul Grootendorst
Health Policy (Amsterdam, Netherlands)
|
June 2, 2022
The effect of patented drug price on the share of new medicines across OECD countries
Oliver Spicer, Paul Grootendorst
International Journal of Health Services : Planning, Administration, Evaluation
|
April 20, 2004
Effects of prescription drug user fees on drug and health services use and on health status in vulnerable populations: a systematic review of the evidence
Joel Lexchin, Paul Grootendorst
Health Economics
|
February 25, 2006
A re-examination of the impact of reference pricing on anti-hypertensive drug plan expenditures in British Columbia
Paul Grootendorst, David Stewart
International Journal for Equity in Health
|
April 19, 2011
Equity in dental care among Canadian households
Carlos Quiñonez, Paul Grootendorst
Journal of Health Economics
|
November 24, 2004
An empirical analysis of milk addiction
M Christopher Auld, Paul Grootendorst
Tobacco Control
|
March 11, 2014
Intended and unintended effects of restrictions on the sale of cigarillos to youth: evidence from Canada
Hai V Nguyen, Paul Grootendorst
Page
of 8
Search research articles
Search
Showing results (1-10 of 72) with videos related to
Sort By:
Page
of 8
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique
|
August 13, 2002
Beneficiary cost sharing under Canadian provincial prescription drug benefit programs: history and assessment
Paul Grootendorst
Expert Review of Pharmacoeconomics & Outcomes Research
|
August 13, 2009
How should we support pharmaceutical innovation?
Paul Grootendorst
BMC Health Services Research
|
November 4, 2022
Pharmacy location and medical need: regional evidence from Canada
Paul Grootendorst
Healthcare Policy = Politiques De Sante
|
November 17, 2015
Canada's New Generic Pricing Policy: A Reasoned Approach to a Challenging Problem
Aidan Hollis, Paul Grootendorst
Health Policy (Amsterdam, Netherlands)
|
June 2, 2022
The effect of patented drug price on the share of new medicines across OECD countries
Oliver Spicer, Paul Grootendorst
International Journal of Health Services : Planning, Administration, Evaluation
|
April 20, 2004
Effects of prescription drug user fees on drug and health services use and on health status in vulnerable populations: a systematic review of the evidence
Joel Lexchin, Paul Grootendorst
Health Economics
|
February 25, 2006
A re-examination of the impact of reference pricing on anti-hypertensive drug plan expenditures in British Columbia
Paul Grootendorst, David Stewart
International Journal for Equity in Health
|
April 19, 2011
Equity in dental care among Canadian households
Carlos Quiñonez, Paul Grootendorst
Journal of Health Economics
|
November 24, 2004
An empirical analysis of milk addiction
M Christopher Auld, Paul Grootendorst
Tobacco Control
|
March 11, 2014
Intended and unintended effects of restrictions on the sale of cigarillos to youth: evidence from Canada
Hai V Nguyen, Paul Grootendorst
Page
of 8